These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 17418289

  • 41. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
    Ahmed TA, Atary JZ, Wolterbeek R, Hasan-Ali H, Abdel-Kader SS, Schalij MJ, Jukema JW.
    J Interv Cardiol; 2012 Feb; 25(1):1-9. PubMed ID: 22059390
    [Abstract] [Full Text] [Related]

  • 42. Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study.
    Tousek P, Rokyta R, Tesarova J, Pudil R, Belohlavek J, Stasek J, Rohac F, Widimsky P.
    Acute Card Care; 2011 Sep; 13(3):116-22. PubMed ID: 21526919
    [Abstract] [Full Text] [Related]

  • 43. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial).
    Nikolsky E, Grines CL, Cox DA, Garcia E, Tcheng JE, Sadeghi M, Mehran R, Lansky AJ, Na Y, Stone GW.
    Am J Cardiol; 2007 Apr 15; 99(8):1055-61. PubMed ID: 17437727
    [Abstract] [Full Text] [Related]

  • 44. Impact of thrombus aspiration on myocardial tissue reperfusion and left ventricular functional recovery and remodeling after primary angioplasty.
    Liistro F, Grotti S, Angioli P, Falsini G, Ducci K, Baldassarre S, Sabini A, Brandini R, Capati E, Bolognese L.
    Circ Cardiovasc Interv; 2009 Oct 15; 2(5):376-83. PubMed ID: 20031746
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
    Ellis SG, Armstrong P, Betriu A, Brodie B, Herrmann H, Montalescot G, Neumann FJ, Smith JJ, Topol E, Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events Investigators.
    Am Heart J; 2004 Apr 15; 147(4):E16. PubMed ID: 15077099
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI.
    Hermanides RS, van Werkum JW, Ottervanger JP, Breet NJ, Gosselink AT, van Houwelingen KG, Dambrink JH, Hamm C, ten Berg JM, van 't Hof AW, Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):956-64. PubMed ID: 22162050
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Janzon M, Mielecki W, Zmudka K, Dubiel JS, Dudek D.
    Kardiol Pol; 2012 May 01; 70(3):215-21. PubMed ID: 22430397
    [Abstract] [Full Text] [Related]

  • 58. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.
    Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, Kastrati A, Schömig A.
    Circulation; 1998 Dec 15; 98(24):2695-701. PubMed ID: 9851955
    [Abstract] [Full Text] [Related]

  • 59. Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine.
    Petronio AS, De Carlo M, Ciabatti N, Amoroso G, Limbruno U, Palagi C, Di Bello V, Romano MF, Mariani M.
    Am Heart J; 2005 Nov 15; 150(5):1015. PubMed ID: 16290987
    [Abstract] [Full Text] [Related]

  • 60. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
    Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, Nekolla SG, Seyfarth M, Martinoff S, Markwardt C, Clermont G, Gerbig HW, Leiss J, Schwaiger M, Schömig A, Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators.
    JAMA; 2004 Feb 25; 291(8):947-54. PubMed ID: 14982910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.